Solid Phase-Based Cross-Matching as Solution for Kidney Allograft Recipients Pretreated with Therapeutic Antibodies

In order to select recipients without donor-specific anti-HLA antibodies, the complement-dependent cytotoxicity crossmatch (CDC-CM) was established as the standard procedure about 40 years ago. However, the interpretability of this functional assay strongly depends on the vitality of isolated donors...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlaf, Gerald, Apel, Susanne, Wahle, Anja, Altermann, Wolfgang W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310493/
https://www.ncbi.nlm.nih.gov/pubmed/25654115
http://dx.doi.org/10.1155/2015/587158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310493/
https://www.ncbi.nlm.nih.gov/pubmed/25654115
http://dx.doi.org/10.1155/2015/587158

Ejemplares similares